Document Detail


New medications which decrease levothyroxine absorption.
MedLine Citation:
PMID:  17725434     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Medications may sometimes interfere with the intestinal absorption of levothyroxine, primarily by forming an insoluble complex with the thyroid hormone in the intestinal lumen. The goal of this study was to examine the acute effects of three previously unstudied medications on levothyroxine absorption. DESIGN: We studied the effects of three medications on thyroxine absorption in seven normal volunteers. On each study day, the subjects ingested 1 mg levothyroxine sodium, either taken separately or co-administered with sevelamer hydrochloride (Renagel, a phosphate-binding medication used in the treatment of hyperphosphatemia), chromium picolinate (an over-the-counter nutritional supplement), or ezetimibe (Zetia, a drug used in the treatment of hypercholesterolemia). Serum thyroxine was measured at intervals over a 6-hour period following drug ingestion. MAIN OUTCOME: Sevelamer hydrochloride and chromium picolinate each significantly (p < 0.05) decreased the area under the serum thyroxine concentration curve, while ezetimibe had no effect. CONCLUSION: Hypothyroid patients taking sevelamer hydrochloride or chromium picolinate should be advised to separate the time of ingestion of these drugs from their thyroid hormone preparation by several hours.
Authors:
Jennifer John-Kalarickal; Gwen Pearlman; Harold E Carlson
Related Documents :
12566504 - Longitudinal and horizontal integration of nutrition science into medical school curric...
2520254 - Nutrition education for medical students: evaluation of the relative contribution of fr...
14967914 - Effects of body condition score in cows peripartum on the onset of postpartum ovarian c...
15736644 - Morbidity and health survey of wintering members in japanese antarctic research expedit...
15228424 - Primary clinical analysis of medical disorders in chinese women with endometrial carcin...
590544 - Fundamental comments on cell polarography according to velazquez and rosado.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Thyroid : official journal of the American Thyroid Association     Volume:  17     ISSN:  1050-7256     ISO Abbreviation:  Thyroid     Publication Date:  2007 Aug 
Date Detail:
Created Date:  2007-08-29     Completed Date:  2008-08-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9104317     Medline TA:  Thyroid     Country:  United States    
Other Details:
Languages:  eng     Pagination:  763-5     Citation Subset:  IM    
Affiliation:
Endocrinology Division, Department of Medicine, Stony Brook University School of Medicine, Stony Brook, New York 11794-8154, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anticholesteremic Agents / administration & dosage
Azetidines / administration & dosage*
Chelating Agents / administration & dosage
Drug Interactions
Female
Humans
Hypercholesterolemia / drug therapy
Hypothyroidism / drug therapy
Intestinal Absorption / drug effects*
Iron Chelating Agents / administration & dosage
Male
Picolinic Acids / administration & dosage*
Polyamines / administration & dosage*
Thyroxine / blood,  pharmacokinetics*
Grant Support
ID/Acronym/Agency:
MO1RR10710/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Azetidines; 0/Chelating Agents; 0/Iron Chelating Agents; 0/Picolinic Acids; 0/Polyamines; 163222-33-1/ezetimibe; 182683-00-7/sevelamer; 7488-70-2/Thyroxine; 98-98-6/picolinic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A dietary iodine questionnaire: correlation with urinary iodine and food diaries.
Next Document:  The effect of infertility medication on thyroid function in hypothyroid women who conceive.